THERACRYF PLC — Investor Relations & Filings
TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Study started of new SFX-01 tablet formulation | 2022-11-16 | English | |
| Second Price Monitoring Extn | 2022-10-21 | English | |
| Price Monitoring Extension | 2022-10-21 | English | |
| Second Price Monitoring Extn | 2022-10-12 | English | |
| Price Monitoring Extension | 2022-10-12 | English | |
| Clinical trial update | 2022-10-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 11142802 | Study started of new SFX-01 tablet formulation | 2022-11-16 | English | ||
| 11137200 | Second Price Monitoring Extn | 2022-10-21 | English | ||
| 11137196 | Price Monitoring Extension | 2022-10-21 | English | ||
| 11134596 | Second Price Monitoring Extn | 2022-10-12 | English | ||
| 11134591 | Price Monitoring Extension | 2022-10-12 | English | ||
| 11134250 | Clinical trial update | 2022-10-12 | English | ||
| 11133783 | Second Price Monitoring Extn | 2022-10-10 | English | ||
| 11133778 | Price Monitoring Extension | 2022-10-10 | English | ||
| 11133648 | SFX-01 licensing deal for up to $160.5m | 2022-10-10 | English | ||
| 11131105 | Regulatory approval for healthy volunteer study | 2022-09-29 | English | ||
| 46830750 | Group of companies' accounts made up to 2022-03-31 | 2022-08-05 | English | ||
| 11114492 | Result of AGM | 2022-07-22 | English | ||
| 11112550 | Investor Presentation | 2022-07-14 | English | ||
| 11108456 | Notice of AGM | 2022-07-06 | English | ||
| 11096458 | Collaboration with University of Michigan | 2022-06-13 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for THERACRYF PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
THERACRYF PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7964/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7964 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7964 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7964 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7964}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for THERACRYF PLC (id: 7964)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.